In the pharmaceutical industry, flooring systems are critical for ensuring production safety and cleanliness. Hunan Dibo Pharmaceutical, a well-known company with over 40 years of experience and a leading market position in artificial bezoar production, recently completed a major upgrade of its production environment. The company selected the KAIDA JINYU PAINT MF system’s polyurethane mortar flooring to create a solid and reliable foundation for its GMP-compliant cleanroom.
01 | A Traditional Pharmaceutical Company’s Pursuit of Quality
Located in Liuyang, Hunan, Dibo Pharmaceutical is a modern enterprise integrating drug R&D, production, and sales. It has long-standing partnerships with renowned companies such as Tongrentang and Kuihua Pharmaceutical, and has always adhered to high standards for its production environment.
The original flooring system had a multi-layer structure: beneath the surface PVC layer were epoxy self-leveling and cement-based self-leveling layers. This complex structure posed significant challenges during the grinding phase of the renovation, requiring a highly specialized technical solution for the upgrade.


02 | The Core of the Upgrade: Why Polyurethane Mortar Pharmaceutical Flooring Was the Essential Choice
The original PVC flooring after being lifted (revealing hidden dirt, bacteria, and unpleasant odors).
Grinding process of the PVC flooring (step-by-step grinding of the original substrate layers).
Polyurethane mortar renovation completed
(Integrated design, sterile and formaldehyde-free).
Faced with the complexity of the existing floor, Dibo Pharmaceutical ultimately chose the KAIDA JINYU PAINT MF system’s polyurethane mortar flooring as the upgrade solution. The core reasons lie in its precise alignment with three critical needs of the pharmaceutical industry:
- GMP Cleanroom Compliance: Polyurethane mortar pharmaceutical flooring features a seamless, monolithic structure that eliminates the risk of dirt accumulation in joints. It withstands frequent disinfection and cleaning (including strong acid and alkaline disinfectants) common in pharmaceutical production, fully complying with GMP requirements for cleanroom flooring.
- Durability and Stability: The material offers exceptional impact resistance and wear durability, capable of withstanding high-intensity use such as equipment movement and material transportation in production areas. This fundamentally addresses the issue of vulnerability seen in the old multi-layer flooring.
- Long-Term Cost-Effectiveness: Although the renovation costs increased due to the difficulty of preparing the old substrate, the polyurethane mortar flooring’s exceptionally long service life (far exceeding that of traditional flooring materials) and very low maintenance requirements perfectly illustrate the principle that “a poorly chosen floor ends up being the most expensive floor.” The hidden waste from repeated repairs and renovations due to an improper initial selection represents a far greater long-term cost.
03 | Project Outcome: A Solid Foundation for Clean Production
The installation of the KAIDA JINYU PAINT MF system’s polyurethane mortar flooring is now complete, providing reliable flooring support for Dibo Pharmaceutical’s production workshops. As a production base for artificial bezoar and other drugs, a clean production environment is crucial for ensuring drug quality. This flooring upgrade further strengthens the cleanliness standards in Dibo’s production processes, laying a solid foundation for the continuous output of high-quality medicines.


About KAIDA JINYU PAINT
KAIDA JINYU PAINT has deep expertise in the pharmaceutical flooring sector, consistently using stringent GMP standards to guide its R&D efforts. The company specializes in developing high-performance polyurethane mortar flooring solutions for pharmaceutical facilities. Supported by a professional technical R&D team and advanced production processes, every step—from raw material selection and formula optimization to construction management—undergoes strict quality testing and validation. We have successfully assisted dozens of leading pharmaceutical companies in upgrading their production floorings, significantly enhancing the cleanliness, abrasion resistance, and chemical resistance of their production environments.
Moving forward, KAIDA JINYU PAINT will continue to increase R&D investment and deepen technical cooperation with industry institutions. With a more professional attitude, innovative products, and attentive service, we are committed to helping pharmaceutical companies strengthen the cleanliness barriers in drug production and jointly promote high-quality development within the industry.